RAPT Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:RAPT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 17.62 M10.44 M52.41 M11.27 M12.46 M 86.58 M Cash from investing activities 18.45 M-843 K57.06 M7.26 M-8.47 M 55.02 M Cash from financing activities 0143.12 M0161 K36 K 143.31 M Free cash flow 17.61 M10.44 M52.37 M11.23 M12.46 M 86.5 M

News

GSK completes $2.2 billion acquisition of RAPT Therapeutics

RAPT Therapeutics stock hits 52-week high at $57.98

Rapt Therapeutics stock hits 52-week high at 57.87 USD

Rapt Therapeutics stock reaches 52-week high at $57.71

GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout

Rapt Therapeutics stock hits 52-week high at $57.62

GSK acquires Rapt Therapeutics stock for $2.2 billion as Leerink downgrades

GSK Digs In On Allergies With $2.2 Billion Rapt Therapeutics Buyout

RAPT Therapeutics: A Buy As GSK Acquisition Highlights Long-Acting IgE Candidate (RAPT)

Shopify, AeroVironment among market cap stock movers on Tuesday

GSK makes $2.2 billion swoop for RAPT Therapeutics’ food allergy drug

Intel and SanDisk among market cap stock movers on Tuesday